SaaS Metrics
Academic Publication Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications
AI Semantic Synergy Context
Connecting this academic literature to real-world market discussions and products.
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies
ImportanceFinding a reliable diagnostic biomarker for the disorders collectively known as synucleinopathies (Parkinson disease [PD], dementia with Lewy bodies [DLB], multiple system atrophy [MSA], ...
Gastrointestinal dysfunction in patients with Mowat–Wilson syndrome is associated with feeding difficulties and altered plasma neurotransmitters
Background Intestinal dysfunction is prevalent in children with Mowat–Wilson syndrome (MWS), yet its underlying mechanisms remain unclear. This study aimed to characterize intestinal symptoms, feed...
Reversing memory loss via gut-brain communication
Aging causes changes in gut bacteria in mice, which hampers communication between the intestines and the brain. Restoring this connection helped old mice form memories as well as young animals.
Why your brain may be sabotaging your balance as you age
Balance problems in aging and Parkinson’s may come from the body working too hard, not too little. Scientists found that the brain and muscles become overactive during even minor disturbances, yet ...
Energy metabolism in health and diseases
Abstract Energy metabolism is indispensable for sustaining physiological functions in living organisms and assumes a pivotal role across physiological and pathological conditions. This re...
Frequently Asked Questions (FAQ)
Curated market intelligence mapped to this research.
What is the core focus of the research titled 'Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications'?
This literature focuses on:
What other academic literature is closely related to 'Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications'?
Yes, highly correlated activity was mapped. An entry titled 'Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies' discusses this: ImportanceFinding a reliable diagnostic biomarker for the disorders collectively known as synucleinopathies (Parkinson disease [PD], dementia with ...
Are there commercial applications of 'Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications' in market news publications?
Yes, highly correlated activity was mapped. An entry titled 'Reversing memory loss via gut-brain communication' discusses this: Aging causes changes in gut bacteria in mice, which hampers communication between the intestines and the brain. Restoring this connection helped ol...
Cite this Market Intelligence Report
Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.